AAAAAA
Results:
1-14
|
Results: 14
Authors:
Kaaks, R
Soderberg, S
Olsson, T
Hallmans, G
Stattin, P
Citation: R. Kaaks et al., Re: Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study - Response, J NAT CANC, 93(8), 2001, pp. 650-651
Authors:
Haggstrom, S
Stattin, P
Wikstrom, P
Bergh, A
Damber, JE
Citation: S. Haggstrom et al., Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancer, BJU INT, 88(1), 2001, pp. 110-116
Authors:
Lukanova, A
Toniolo, P
Akhmedkhanov, A
Hunt, K
Rinaldi, S
Zeleniuch-Jacquotte, A
Haley, NJ
Riboli, E
Stattin, P
Lundin, E
Kaaks, R
Citation: A. Lukanova et al., A cross-sectional study of IGF-1 determinants in women, EUR J CAN P, 10(5), 2001, pp. 443-452
Authors:
Tieva, A
Stattin, P
Wikstrom, P
Bergh, A
Damber, JE
Citation: A. Tieva et al., Gonadotropin-releasing hormone receptor expression in the human prostate, PROSTATE, 47(4), 2001, pp. 276-284
Authors:
Stattin, P
Stenman, UH
Riboli, E
Hallmans, G
Kaaks, R
Citation: P. Stattin et al., Prostate cancer screening, LANCET, 357(9263), 2001, pp. 1202-1203
Authors:
Stattin, P
Kaaks, R
Riboli, E
Ferrari, P
Dechaud, H
Hallmans, G
Citation: P. Stattin et al., Circulating insulin-like growth factor-I and benign prostatic hyperplasia - A prospective study, SC J UROL N, 35(2), 2001, pp. 122-126
Authors:
Ljungberg, B
Bozoky, B
Kovacs, G
Stattin, P
Farrelly, E
Nylander, K
Landberg, G
Citation: B. Ljungberg et al., p53 expression in correlation to clinical outcome in patients with renal cell carcinoma, SC J UROL N, 35(1), 2001, pp. 15-20
Authors:
Stattin, P
Soderberg, S
Hallmans, G
Bylund, A
Kaaks, R
Stenman, UH
Bergh, A
Olsson, T
Citation: P. Stattin et al., Leptin is associated with increased prostate cancer risk: A nested case-referent study, J CLIN END, 86(3), 2001, pp. 1341-1345
Authors:
Stattin, P
Rinaldi, S
Stenman, UH
Riboli, E
Hallmans, G
Bergh, A
Kaaks, R
Citation: P. Stattin et al., Plasma prolactin and prostate cancer risk: A prospective study, INT J CANC, 92(3), 2001, pp. 463-465
Authors:
Stattin, P
Bylund, A
Rinaldi, S
Biessy, C
Dechaud, H
Stenman, UH
Egevad, L
Riboli, E
Hallmans, G
Kaaks, R
Citation: P. Stattin et al., Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study, J NAT CANC, 92(23), 2000, pp. 1910-1917
Authors:
Lissbrant, IF
Stattin, P
Wikstrom, P
Damber, JE
Egevad, L
Bergh, A
Citation: If. Lissbrant et al., Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival, INT J ONCOL, 17(3), 2000, pp. 445-451
Authors:
Wikstrom, P
Wikstrom, P
Lissbrant, IF
Bergh, A
Damber, JE
Stattin, P
Citation: P. Wikstrom et al., Evaluation of prognostic factors in prostate cancer with partial least squares analysis, SC J UROL N, 34(4), 2000, pp. 252-256
Authors:
Wikstrom, P
Westin, P
Stattin, P
Damber, JE
Bergh, A
Citation: P. Wikstrom et al., Early castration-induced upregulation of transforming growth factor beta 1and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients, PROSTATE, 38(4), 1999, pp. 268-277
Authors:
Bylund, A
Stattin, P
Widmark, A
Bergh, A
Citation: A. Bylund et al., Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy, RADIOTH ONC, 49(2), 1998, pp. 143-148
Risultati:
1-14
|